Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Healthcare Deals This Week: Merck, Sofinnova, Lilly No Photo Available

Yeji Jesse Lee

Merck and Eli Lilly announced billion-dollar transactions set to give them an in on new treatments. Pfizer was victorious after beatin... (more story)

Eye Doc's Hospital Competition Lawsuit Gets NC Panel Trial No Photo Available

Mark Payne

Five years after being denied “certificate of need” application for an eye surgery center, a North Carolina doctor was in court Tuesda... (more story)

Doctors, Lawmakers Fight Downcoding, Citing Patient Harm No Photo Available

Hannah Albarazi

Healthcare providers are sounding the alarm on automated downcoding, an aggressive cost-saving strategy by health insurers. While heal... (more story)